CN102659643B - 一种由α,β-不饱和酰胺制备取代高牛磺酸的方法 - Google Patents
一种由α,β-不饱和酰胺制备取代高牛磺酸的方法 Download PDFInfo
- Publication number
- CN102659643B CN102659643B CN201210113527.6A CN201210113527A CN102659643B CN 102659643 B CN102659643 B CN 102659643B CN 201210113527 A CN201210113527 A CN 201210113527A CN 102659643 B CN102659643 B CN 102659643B
- Authority
- CN
- China
- Prior art keywords
- homotaurine
- acid
- preparation
- reduction
- method replacing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- -1 beta-unsaturated acyl amine Chemical class 0.000 title claims description 56
- SNKZJIOFVMKAOJ-UHFFFAOYSA-N 3-Aminopropanesulfonate Chemical compound NCCCS(O)(=O)=O SNKZJIOFVMKAOJ-UHFFFAOYSA-N 0.000 title claims description 31
- 238000000034 method Methods 0.000 title claims description 15
- 238000002360 preparation method Methods 0.000 claims description 33
- 238000006722 reduction reaction Methods 0.000 claims description 20
- 230000009467 reduction Effects 0.000 claims description 18
- 125000004432 carbon atom Chemical group C* 0.000 claims description 13
- 238000007254 oxidation reaction Methods 0.000 claims description 12
- 230000003647 oxidation Effects 0.000 claims description 11
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 10
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 8
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- 150000001408 amides Chemical class 0.000 claims description 6
- 150000002431 hydrogen Chemical class 0.000 claims description 6
- KOUKXHPPRFNWPP-UHFFFAOYSA-N pyrazine-2,5-dicarboxylic acid;hydrate Chemical compound O.OC(=O)C1=CN=C(C(O)=O)C=N1 KOUKXHPPRFNWPP-UHFFFAOYSA-N 0.000 claims description 6
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 5
- 125000003118 aryl group Chemical group 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 5
- QPFMBZIOSGYJDE-UHFFFAOYSA-N 1,1,2,2-tetrachloroethane Chemical compound ClC(Cl)C(Cl)Cl QPFMBZIOSGYJDE-UHFFFAOYSA-N 0.000 claims description 4
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 claims description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 4
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- 238000007259 addition reaction Methods 0.000 claims description 4
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 claims description 4
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 claims description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 4
- 235000019253 formic acid Nutrition 0.000 claims description 4
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 claims description 4
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims description 4
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims description 3
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 claims description 3
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 claims description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- 229910015900 BF3 Inorganic materials 0.000 claims description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 2
- SCKXCAADGDQQCS-UHFFFAOYSA-N Performic acid Chemical compound OOC=O SCKXCAADGDQQCS-UHFFFAOYSA-N 0.000 claims description 2
- 235000011054 acetic acid Nutrition 0.000 claims description 2
- 229910000085 borane Inorganic materials 0.000 claims description 2
- HPYNZHMRTTWQTB-UHFFFAOYSA-N dimethylpyridine Natural products CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 claims description 2
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 claims description 2
- 239000012280 lithium aluminium hydride Substances 0.000 claims description 2
- OOHAUGDGCWURIT-UHFFFAOYSA-N n,n-dipentylpentan-1-amine Chemical compound CCCCCN(CCCCC)CCCCC OOHAUGDGCWURIT-UHFFFAOYSA-N 0.000 claims description 2
- 235000019260 propionic acid Nutrition 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 2
- 239000012279 sodium borohydride Substances 0.000 claims description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 2
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 claims description 2
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 claims description 2
- 229940005605 valeric acid Drugs 0.000 claims description 2
- 239000007810 chemical reaction solvent Substances 0.000 claims 3
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 claims 2
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 claims 2
- 230000001590 oxidative effect Effects 0.000 claims 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims 1
- CMEWLCATCRTSGF-UHFFFAOYSA-N N,N-dimethyl-4-nitrosoaniline Chemical compound CN(C)C1=CC=C(N=O)C=C1 CMEWLCATCRTSGF-UHFFFAOYSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 14
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 14
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 14
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 13
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 13
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 13
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 13
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 13
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 13
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 13
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 13
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 13
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 13
- 238000002844 melting Methods 0.000 description 12
- 230000008018 melting Effects 0.000 description 12
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 10
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 10
- 239000002994 raw material Substances 0.000 description 10
- 125000003229 2-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 9
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 9
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 9
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 9
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 9
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 8
- 125000004344 phenylpropyl group Chemical group 0.000 description 8
- 239000013078 crystal Substances 0.000 description 7
- NQQRXZOPZBKCNF-NSCUHMNNSA-N (e)-but-2-enamide Chemical compound C\C=C\C(N)=O NQQRXZOPZBKCNF-NSCUHMNNSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 5
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 5
- XXIKKBPTWQTKFG-UHFFFAOYSA-N 3-(dibenzylamino)propane-1-sulfonic acid Chemical compound C=1C=CC=CC=1CN(CCCS(=O)(=O)O)CC1=CC=CC=C1 XXIKKBPTWQTKFG-UHFFFAOYSA-N 0.000 description 4
- NHQAUSOKYWFWHO-UHFFFAOYSA-N 4-aminobutane-2-sulfonic acid Chemical compound OS(=O)(=O)C(C)CCN NHQAUSOKYWFWHO-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- CPPHSWZWNSTFGV-UHFFFAOYSA-N 3-(benzylamino)propane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCNCC1=CC=CC=C1 CPPHSWZWNSTFGV-UHFFFAOYSA-N 0.000 description 3
- HVGIUNGSUCQGDX-UHFFFAOYSA-N 3-amino-2-methylpropane-1-sulfonic acid Chemical compound NCC(C)CS(O)(=O)=O HVGIUNGSUCQGDX-UHFFFAOYSA-N 0.000 description 3
- VLFLRNSLXSSUJZ-UHFFFAOYSA-N 3-amino-2-phenylpropane-1-sulfonic acid Chemical compound OS(=O)(=O)CC(CN)C1=CC=CC=C1 VLFLRNSLXSSUJZ-UHFFFAOYSA-N 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 238000006845 Michael addition reaction Methods 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000006165 cyclic alkyl group Chemical group 0.000 description 2
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 description 2
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- FSSPGSAQUIYDCN-UHFFFAOYSA-N 1,3-Propane sultone Chemical compound O=S1(=O)CCCO1 FSSPGSAQUIYDCN-UHFFFAOYSA-N 0.000 description 1
- AOSFMYBATFLTAQ-UHFFFAOYSA-N 1-amino-3-(benzimidazol-1-yl)propan-2-ol Chemical compound C1=CC=C2N(CC(O)CN)C=NC2=C1 AOSFMYBATFLTAQ-UHFFFAOYSA-N 0.000 description 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
- MXZROAOUCUVNHX-UHFFFAOYSA-N 2-Aminopropanol Chemical compound CCC(N)O MXZROAOUCUVNHX-UHFFFAOYSA-N 0.000 description 1
- ZGDKDTLIVOMOHM-UHFFFAOYSA-N 2-methyl-4-oxopentanethioamide Chemical compound NC(=S)C(C)CC(C)=O ZGDKDTLIVOMOHM-UHFFFAOYSA-N 0.000 description 1
- KFTHUBZIEMOORC-UHFFFAOYSA-N 2-methylbut-2-enamide Chemical compound CC=C(C)C(N)=O KFTHUBZIEMOORC-UHFFFAOYSA-N 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- IMOLAGKJZFODRK-UHFFFAOYSA-N 2-phenylprop-2-enamide Chemical compound NC(=O)C(=C)C1=CC=CC=C1 IMOLAGKJZFODRK-UHFFFAOYSA-N 0.000 description 1
- JUSFREYWMBSZKO-UHFFFAOYSA-N 4-oxo-2-phenylpentanethioamide Chemical compound C1(=CC=CC=C1)C(C(=S)N)CC(C)=O JUSFREYWMBSZKO-UHFFFAOYSA-N 0.000 description 1
- AWQSAIIDOMEEOD-UHFFFAOYSA-N 5,5-Dimethyl-4-(3-oxobutyl)dihydro-2(3H)-furanone Chemical compound CC(=O)CCC1CC(=O)OC1(C)C AWQSAIIDOMEEOD-UHFFFAOYSA-N 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 102000013455 Amyloid beta-Peptides Human genes 0.000 description 1
- 108010090849 Amyloid beta-Peptides Proteins 0.000 description 1
- 206010003805 Autism Diseases 0.000 description 1
- 208000020706 Autistic disease Diseases 0.000 description 1
- 241000258920 Chilopoda Species 0.000 description 1
- 238000006969 Curtius rearrangement reaction Methods 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 229910010082 LiAlH Inorganic materials 0.000 description 1
- FTZVQYUSQWLUEU-UHFFFAOYSA-N N-benzyl-4-oxopentanethioamide Chemical compound C(C1=CC=CC=C1)NC(CCC(C)=O)=S FTZVQYUSQWLUEU-UHFFFAOYSA-N 0.000 description 1
- BXEFQPCKQSTMKA-UHFFFAOYSA-N OC(=O)C=[N+]=[N-] Chemical compound OC(=O)C=[N+]=[N-] BXEFQPCKQSTMKA-UHFFFAOYSA-N 0.000 description 1
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical group ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- BUVGWDNTAWHSKI-UHFFFAOYSA-L acamprosate calcium Chemical compound [Ca+2].CC(=O)NCCCS([O-])(=O)=O.CC(=O)NCCCS([O-])(=O)=O BUVGWDNTAWHSKI-UHFFFAOYSA-L 0.000 description 1
- 229960001157 acamprosate calcium Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- UTBIMNXEDGNJFE-UHFFFAOYSA-N collidine Natural products CC1=CC=C(C)C(C)=N1 UTBIMNXEDGNJFE-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000006352 cycloaddition reaction Methods 0.000 description 1
- 125000006453 cyclobutyl cyclopropyl group Chemical group 0.000 description 1
- 125000004850 cyclobutylmethyl group Chemical group C1(CCC1)C* 0.000 description 1
- 125000006622 cycloheptylmethyl group Chemical group 0.000 description 1
- 125000006623 cyclooctylmethyl group Chemical group 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- MDKXBBPLEGPIRI-UHFFFAOYSA-N ethoxyethane;methanol Chemical compound OC.CCOCC MDKXBBPLEGPIRI-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- MIVGZOMJVVQBAO-UHFFFAOYSA-N n,n-dibenzylprop-2-enamide Chemical compound C=1C=CC=CC=1CN(C(=O)C=C)CC1=CC=CC=C1 MIVGZOMJVVQBAO-UHFFFAOYSA-N 0.000 description 1
- OHLHOLGYGRKZMU-UHFFFAOYSA-N n-benzylprop-2-enamide Chemical compound C=CC(=O)NCC1=CC=CC=C1 OHLHOLGYGRKZMU-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 description 1
- 239000002581 neurotoxin Substances 0.000 description 1
- 231100000618 neurotoxin Toxicity 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 150000004967 organic peroxy acids Chemical class 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000005648 plant growth regulator Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- KPBSJEBFALFJTO-UHFFFAOYSA-N propane-1-sulfonyl chloride Chemical compound CCCS(Cl)(=O)=O KPBSJEBFALFJTO-UHFFFAOYSA-N 0.000 description 1
- 125000006308 propyl amino group Chemical class 0.000 description 1
- 238000006268 reductive amination reaction Methods 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 238000006277 sulfonation reaction Methods 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 229950011008 tetrachloroethylene Drugs 0.000 description 1
- 229960003570 tramiprosate Drugs 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明提供了一种取代高牛磺酸的制备方法:通过硫代乙酸对α,β-不饱和酰胺的加成得到相应的3-乙酰硫基酰胺,再经过还原和氧化得到取代高牛磺酸。该制备方法原料简单易得,操作方便,不需要繁琐的除盐纯化过程,特别适合于大规模的工业化生产。所得到的化合物可以作为营养物质、药物、酶抑制剂、抗菌剂、表面活性剂、植物生长调节剂、制备磺酰肽的原料等。
Description
技术领域
本发明属于有机合成技术领域,具体涉及取代高牛磺酸的制备方法。
背景技术
高牛磺酸,即3-氨基丙磺酸,是一种从舌状蜈蚣藻中分离得到的氨基烷基磺酸,其在结构上类似于神经递质γ-氨基丁酸, 研究发现其具有γ-氨基丁酸的抗惊厥功效(Fariello, R. G.; Golden, G. T.; Pisa, M. Neurology 1982, 32, 241)。高牛磺酸还可以防止和治疗结膜鞘的硬化,防脱发,治疗酒精依赖症、抑制体内儿茶酚胺的氧化、保护DNA免受氧化损伤、改善记忆、强心、降血压等作用(Mayer, J.; Cook, A. M. J. Bacteriol. 2009, 191, 6052; Rouhani, S.; Dallava Santucci, J.; Bajenaru, O.; Emmanouilidis, E.; Tran, G.; Manicom, R.; Dinh-xuan, A. T.; Poenaru, S. Pharmacol., Biochem. Behav. 1998, 59, 955; Biasetti, M.; Dawson, R. Jr. Amino Acids. 2002, 22, 351; Messina, S. A.; Dawson, R. Jr. Adv. Exp. Med. Biol. 2000, 483, 355)。因为其对合并症和特发性自闭症有很好的疗效,而受到人们更多的关注。由于它能够与可溶性β淀粉样蛋白结合,抑制能够导致大脑中淀粉样蛋白斑块沉积的神经毒素的形成,用于治疗阿尔茨海默(Alzheimer)病(Aisen, P.S.; Gauthier, S.; Vellas, B.; Eriand, R.; Saumier, D.; Laulin, J.; Garceau, D. Curr. Alzheimer Res. 2007, 4, 473; Gauthier, S.; Aisen, P. S.; Ferris, S. H.; Saumier, D. J. Nutr. Health Aging. 2009, 13, 550)。以高牛磺酸为主要成分开发的药物阿坎酸钙和Tramiprosate也取得了很好的疗效(Erickson, C. A. WO 2010093859;Wright, T. M. Drugs Today, 2006, 42, 291)。
不同结构的取代高牛磺酸具有不同的生物功能和药效,发展结构多样性的取代高牛磺酸的有效和通用的合成方法对于新药开发具有非常重要意义。已报道的高牛磺酸和取代高牛磺酸的制备方法包括:通过亚硫酸氢盐或亚硫酸盐对3-卤代胺的亲核取代制备(张秋材,丁敏,李文忠,程志鹏,梁隆,中国发明专利公开说明书, CN 1451652A;Sen, N. P. Can. J. Chem. 1962, 40, 2189);通过亚硫酸盐对不饱和腈的迈克尔加成再还原来制备(凌建红,徐伟,中国发明专利公开说明书, CN 101362709A;Li, C. S.; Howson, W.; Dolle, R. E. Synthesis 1991, 3, 244);通过亚硫酸氢盐对2-甲基丙烯醛的迈克尔加成再还原胺化来制备(Smith, C. W.; Norton, D. G.; Ballard, S. A. J. Am. Chem. Soc. 1953, 75, 748);通过亚硫酸氢铵对2-芳基取代的丙烯胺磺化制备(Abbenante, G; Prager, R. H. Aust. J. Chem. 1990, 43, 213; Abbenante, G; Prager, R. H. Aust. J. Chem. 1992, 45, 1791);通过亚硫酸氢铵对a-溴甲基苯乙烯的取代、加成和还原制备或硫代乙酸对a-氨甲基苯乙烯的加成和氧化制备(Abbenante, G; Prager, R. H. Aust. J. Chem. 1992, 45, 1801);通过伯胺对3-溴丙磺酰氯的取代制备(Millan, D. S.; Prager, R. H. Aust. J. Chem. 2000, 53, 615);通过亚硫酸盐对氨基丙醇磺酸酯的亲核取代制备(贺辙,刘遗松,朱文杰,邵学青,严志华,顾仁华,钱继新,赵婷,中国发明专利公开说明书, CN 101759605A);通过氨、叠氮或者伯胺对1,3-丙磺内酯的亲核开环来制备(Erman, Wm. F.; Kretschmar, H. C. J. Org. Chem. 1961 , 26, 4841;张秋材,丁敏,李文忠,程志鹏,梁隆,中国发明专利公开说明书, CN 1442405A; Dieter, E.; Wacharee, H. Synthesis 2004 , 17, 2910; Kong, X.; Migneault, D.; Wu, X. WO 2004113391;Kong, X.; Migneault, D.; Valade, I.; Wu, X.; Gervais, F. US 20070010573);通过过渡金属催化的α-重氮甲基磺酸酯与相应烯丙胺的环加成或烯丙基磺酸酯与重氮乙酸酯环加成,将产物转化成酰基叠氮,及其后续的Curtius重排制备(Fulco, M. C.; Marinozzi, M.; Pellicciari, R. Tetrahedron 2009, 65, 8756)
已有这些方法都可以用来合成高牛磺酸或取代高牛磺酸,但往往由于原料限制,只能合成某些结构类型的取代高牛磺酸,或需要麻烦的除盐纯化过程。本发明通过硫代乙酸对α,β-不饱和酰胺的加成得到相应的3-乙酰硫基酰胺,再经过还原和氧化得到取代高牛磺酸,该方法的最后一步为无盐过程,方便对水溶性离子型产物取代高牛磺酸的分离纯化,可用于制备高纯度的取代高牛磺酸。
发明内容
本发明的目的是提供一种取代高牛磺酸的无盐制备方法,该制备方法原料简单易得,是一种适合于大规模工业生产的有效制备取代高牛磺酸的简便方法。
本发明的技术方案如下:
一种取代高牛磺酸的制备方法,通过硫代乙酸对α,β-不饱和酰胺的加成得到相应的3-乙酰硫基酰胺,再经过还原和氧化得到取代高牛磺酸。
上述反应式中:
R1、R2、R3和R4表示氢、烷基、环烷基、环烷基烷基、芳基、芳烷基等,其中烷基和芳烷基中的烷基均可以为环状,环烷基和芳基可以是骈环,但R1、R2、R3和R4不同时为氢。
其中所述的烷基是指具有1~15个碳原子的直链或支链烷基,例如:甲基、乙基、丙基、异丙基、丁基、异丁基、叔丁基、仲丁基、戊基、异戊基、仲戊基、新戊基、己基、异己基、仲己基、庚基、异庚基、仲庚基等。优选具有1~12个碳原子的直链或支链烷基,特别优选具有3~10个碳原子的直链或支链烷基,最优选具有3~8个碳原子的直链或支链烷基。
所述的环烷基是指具有3~15个碳原子的环状烷基,例如环丙基、环丁基、环戊基、环己基、环庚基、环辛基等,优选环丙基、环戊基、环己基、环庚基、环辛基。
所述的环烷基烷基是指具有4~15个碳原子的环状烷基,例如环丙基甲基、环丁基甲基、环戊基甲基、环己基甲基、环庚基甲基、环辛基甲基、环丙基乙基、环丁基乙基、环戊基乙基、环己基乙基、环庚基乙基、环辛基乙基、环丙基丙基、环丁基丙基、环戊基丙基、环己基丙基、环庚基丙基、环辛基丙基等,优选环丙基甲基、环戊基甲基、环己基甲基、环庚基甲基、环丙基乙基、环戊基乙基、环己基乙基、环庚基乙基、环丙基丙基、环戊基丙基、环己基丙基、环庚基丙基。
所述的芳基是指具有6~15个碳原子的芳基。优选为苯基、取代苯基、1-萘基、2-萘基、联苯基、取代萘基等。
所述的芳烷基是指具有7~15个碳原子的芳烷基。优选为苯甲基、取代苯甲基、1-萘甲基、2-萘甲基、联苯甲基、取代萘甲基等。
优选的R1代表氢、甲基、乙基、丙基、异丙基、丁基、异丁基、叔丁基、仲丁基、戊基、异戊基、仲戊基、新戊基、己基、异己基、仲己基、庚基、异庚基、仲庚基、环丙基、环丁基、环戊基、环己基、环庚基、环辛基、苯甲基、苯乙基、苯丙基、苯丁基,更优选甲基、乙基、丙基、异丙基、丁基、异丁基、叔丁基、仲丁基、戊基、异戊基、仲戊基、己基、异己基、仲己基、庚基、异庚基、仲庚基、环丙基、环戊基、环己基、环庚基、苯基、苯甲基、苯乙基、苯丙基,最优选甲基、乙基、丙基、异丙基、丁基、异丁基、戊基、异戊基、己基、异己基、环戊基、环己基、苯基、苯甲基。
优选的R2代表氢、甲基、乙基、丙基、异丙基、丁基、异丁基、叔丁基、仲丁基、戊基、异戊基、仲戊基、新戊基、己基、异己基、仲己基、庚基、异庚基、仲庚基、环丙基、环丁基、环戊基、环己基、环庚基、环辛基、苯甲基、苯乙基、苯丙基、苯丁基,更优选甲基、乙基、丙基、异丙基、丁基、异丁基、叔丁基、仲丁基、戊基、异戊基、仲戊基、己基、异己基、仲己基、庚基、异庚基、仲庚基、环丙基、环戊基、环己基、环庚基、苯基、苯甲基、苯乙基、苯丙基,最优选甲基、乙基、丙基、异丙基、丁基、异丁基、戊基、异戊基、己基、异己基、环戊基、环己基、苯基、苯甲基。
优选的R3代表氢、甲基、乙基、丙基、异丙基、丁基、异丁基、叔丁基、仲丁基、戊基、异戊基、仲戊基、新戊基、己基、异己基、仲己基、庚基、异庚基、仲庚基、环丙基、环丁基、环戊基、环己基、环庚基、环辛基、苯甲基、苯乙基、苯丙基、苯丁基,更优选甲基、乙基、丙基、异丙基、丁基、异丁基、叔丁基、仲丁基、戊基、异戊基、仲戊基、己基、异己基、仲己基、庚基、异庚基、仲庚基、环丙基、环戊基、环己基、环庚基、苯基、苯甲基、苯乙基、苯丙基,最优选甲基、乙基、丙基、异丙基、丁基、异丁基、戊基、异戊基、己基、异己基、环戊基、环己基、苯基、苯甲基。
优选的R4代表氢、甲基、乙基、丙基、异丙基、丁基、异丁基、叔丁基、仲丁基、戊基、异戊基、仲戊基、新戊基、己基、异己基、仲己基、庚基、异庚基、仲庚基、环丙基、环丁基、环戊基、环己基、环庚基、环辛基、苯甲基、苯乙基、苯丙基、苯丁基,更优选甲基、乙基、丙基、异丙基、丁基、异丁基、叔丁基、仲丁基、戊基、异戊基、仲戊基、己基、异己基、仲己基、庚基、异庚基、仲庚基、环丙基、环戊基、环己基、环庚基、苯基、苯甲基、苯乙基、苯丙基,最优选甲基、乙基、丙基、异丙基、丁基、异丁基、戊基、异戊基、己基、异己基、环戊基、环己基、苯基、苯甲基。
所制备的取代高牛磺酸例如下述4a~4f六种化合物:
4a:R1 = Me, R2 = R3 = R4 = H;
4b:R1 = R3 = R4 = H, R2 = Me;
4c:R1 = R3 = R4 = H, R2 = Ph;
4d:R1 = R2 = Me, R3 = R4 = H;
4e:R1 = R2 = R3 = H, R4 = Bn;
4f:R1 = R2 = H, R3 = R4 = Bn
上述的制备方法,通常是通过硫代乙酸对α,β-不饱和酰胺的加成得到相应的3-乙酰硫基酰胺,再经过还原和氧化得到取代高牛磺酸。
上述的制备方法,所述原料用的α,β-不饱和酰胺可以通过公开的商业市场渠道购买到,或通过文献报道的合成方法制备。
上述的制备方法,所述加成反应的催化剂碱通常是有机碱三级胺,如三甲胺、三乙胺、三丙胺、三丁胺、三戊胺、乙基二异丙基胺等,N,N-二甲基苯胺、N,N-二乙基苯胺、吡啶,二甲基吡啶,三甲基吡啶等。
上述的制备方法,所述还原方法通常是氢化锂铝还原、硼烷还原、硼氢化钠和三氟化硼的混和物还原、催化氢化等。
上述的制备方法,所述氧化剂通常是有机过酸、胺N-氧化物,及其他氧化剂。
上述的制备方法,通常在0°C~110°C的温度下搅拌反应1~24 h。
上述的制备方法,加成反应通常所用的溶剂为二氯甲烷、氯仿、四氯化碳、二氯乙烷、三氯乙烷、四氯乙烷、四氯乙烯等卤代烃或它们的混和物。
上述的制备方法,还原反应通常所用的溶剂为乙醚、丙醚、四氢呋喃、二氧六环、乙二醇二甲醚或它们的混和物。
上述的制备方法,氧化反应通常所用的溶剂为甲酸、乙酸、丙酸、丁酸、戊酸、己酸、庚酸、辛酸、壬酸、癸酸、水或它们的混和物。
本发明的优点和积极效果:
本发明制备的取代高牛磺酸因其生物活性具有潜在的药用价值,可以作为药物、酶抑制剂、抗菌剂、表面活性剂、植物生长调节剂、制备抗体酶的半抗原、合成磺酰肽的原料等。
本发明提供的制备方法,以简单易得的α,β-不饱和酰胺为原料,其可以通过公开的商业市场渠道购买到或按文献报道的已知方法来制备。该方法操作简单,可以用于合成结构多样性的取代高牛磺酸,适合于大规模工业化生产,对于氨基烷基磺酸研究与应用具有十分重要的意义。
具体实施方式
下面通过实施例的方式进一步说明本发明,并不因此将本发明限制在所述实施例的范围之中。
实施例一
1-氨基-3-丁磺酸4a的制备
在50 mL三口瓶中,将2-丁烯酰胺0.851 g (10 mmol)加入到15 mL CH2Cl2中,随后滴入5滴无水三乙胺。氮气保护下加热至回流,滴加硫代乙酸0.952 g (12.5 mmol),并回流20 h。冷却至室温,除去溶剂后硅胶柱色谱分离 [石油醚(PE):乙酸乙酯(EA) =1:2, v/v] 得中间体3-乙酰硫基丁酰胺1.251 g,收率77.6%。
100 mL单口瓶中,冰水浴下将1.520 g (40 mmol) LiAlH4 加入到30 mL无水THF中。随后滴加含有0.645 g (4 mmol) 3-乙酰硫基丁酰胺的5 mL THF溶液,加热回流18 h,恢复室温后在冰水浴下用水淬灭,加入10 mL水搅拌12 h。过滤,滤液用CH2Cl2萃取三次(10 mL ′3),除去溶剂后得到黄色油状物。将黄色油状物置于25 mL单口瓶中,加入5 mL甲酸,滴加过氧甲酸(5 mL甲酸+2 mL30%过氧化氢),常温下搅拌15 h。除去溶剂后,用甲醇-乙醚重结晶得1-氨基-3-丁磺酸0.120 g,收率19.6%。白色固体,熔点:281-283 oC,文献熔点:288-289 oC。1H NMR (400 MHz, D2O) δ: 3.16-3.04 (m, 2H, CH2N), 2.94 (ddq, J = 6.8, 6.8, 6.8 Hz, 1H in CH), 2.12 (ddt, J = 6.8, 14.8, 6.4 Hz, 1H in CH2), 1.82 (ddt, J = 6.8, 14.8, 6.4 Hz, 1H in CH2), 1.25 (d, J = 6.8 Hz, 3H in CH3); 13C NMR (100 MHz, D2O) δ: 53.0, 37.3, 29.2, 14.6.
实施例二
2-甲基-3-氨基丙磺酸4b的制备
按实施例一中描述的方法,用2-甲基丙烯酰胺代替2-丁烯酰胺为原料,以95%的产率得到2-甲基-3-乙酰硫基丙酰胺无色晶体中间体,熔点84-86 oC;还原和氧化后得到无色晶体2-甲基-3-氨基丙磺酸,产率70%,熔点234-238 oC。文献熔点:260-265 oC。1H NMR (400 MHz, D2O) δ: 3.15 (dd, J = 6.0, 13.2 Hz, 1H in SCH2), 2.93 (dd, J = 6.8, 14.4 Hz, 1H in NCH2), 2.90 (dd, J = 6.8, 13.2 Hz, 1H in SCH2), 2.87 (dd, J = 6.0, 14.4 Hz, 1H in NCH2), 2.32 (ttq, J = 6.8, 6.0,6.8 Hz, 1H, CH), 1.10 (d, J = 6.8 Hz, 3H, CH3); 13C NMR (100 MHz, D2O) δ: 54.7, 44.2, 28.7, 17.0; IR n (cm-1): 3451 (br, s, NH, OH), 1280 (SO), 1176 (SO).
实施例三
2-甲基-1-氨基-3-丁磺酸4c的制备
按实施例一中描述的方法,用2-甲基-2-丁烯酰胺代替2-丁烯酰胺为原料,以75%的产率得到2-甲基-3-乙酰硫基丁酰胺无色晶体中间体,熔点136-138oC;还原和氧化后得到油状2-甲基-1-氨基-3-丁磺酸,产率40%。1H NMR (400 MHz, D2O) δ: 3.27 (dd, J = 5.6, 13.2 Hz, 1H in NCH2), 2.96 (dq, J = 2.8, 7.2 Hz, 1H, SCH), 2.82 (dd, J = 8.4, 13.2 Hz, 1H in NCH2), 2.42 (dddq, J = 2.8, 5.6, 8.4, 7.2 Hz, 1H, CH), 1.21 (d, J = 7.2 Hz, 3H, CH3), 1.05 (d, J = 7.2 Hz, 3H, CH3); 13C NMR (100 MHz, D2O) δ: 58.5, 41.2, 32.3, 15.4, 9.8; IR n (cm-1): 2976 (br, s, NH, OH), 1205 (SO), 1030 (SO). HRMS (ESI, m/z) calcd. for C5H13NO3S [M+H] + m/z: 168.0689; found: 168.0682.
实施例四
2-苯基-3-氨基丙磺酸4d的制备
按实施例一中描述的方法,用2-苯基丙烯酰胺代替2-丁烯酰胺为原料,以70%的产率得到2-苯基-3-乙酰硫基丙酰胺无色晶体中间体,熔点116-117 oC;还原和氧化后得到无色晶体2-苯基-3-氨基丙磺酸,产率74%,熔点220-225 oC,文献熔点:260-265 oC。1H NMR (400 MHz, D2O) δ: 7.40-7.30 (m, 5H, ArH), 3.53 (dd, J = 5.2, 12.8 Hz, 1H in SCH2), 3.46-3.38 (m, 1H, CH), 3.28 (dd, J = 6.4, 14.4 Hz, 1H in NCH2), 3.24 (m, 1H in SCH2), 3.22 (dd, J = 6.4, 14.4 Hz, 1H in NCH2); 13C NMR (100 MHz, D2O) δ: 134.7, 129.4, 128.9, 58.6, 30.3, 16.8; IR n (cm-1): 2960 (br, s, NH, OH), 1180 (SO), 1142 (SO).
实施例五
3-苄氨基丙磺酸4e的制备
按实施例一中描述的方法,用N-苄基丙烯酰胺代替2-丁烯酰胺为原料,以94%的产率得到N-苄基-3-乙酰硫基丙酰胺无色晶体中间体,熔点80-80.5 oC;还原和氧化后得到无色晶体3-苄氨基丙磺酸,产率22%,熔点241-243 oC,文献熔点302-303 oC。1H NMR (400 MHz, D2O) δ: 7.42 (s, 5H, ArH), 4.17 (s, 2H, CH2), 3.15 (t, J = 7.2 Hz, 2H, SCH2), 2.91 (t, J = 7.2 Hz, 2H, NCH2), 2.06 (quint, J = 7.2 Hz, 2H, CH2); 13C NMR (100 MHz, D2O) δ: 130.6, 129.8, 129.7, 129.3, 51.1, 47.9, 45.7, 21.3; IR n (cm-1): 3452 (br, s, NH, OH), 1245 (SO), 1184, (SO).
实施例六
3-二苄氨基丙磺酸4f的制备
按实施例一中描述的方法,用N,N-二苄基丙烯酰胺代替2-丁烯酰胺为原料,以77%的产率得到N,N-二苄基-3-乙酰硫基丙酰胺油状中间体;还原和氧化后得到油状3-二苄氨基丙磺酸,产率76%。1H NMR (400 MHz, D2O) δ: 7.45-7.32 (m, 10H, ArH), 4.22 (s, 4H, 2CH2), 3.16 (m, 2H, SCH2), 2.75 (t, J = 7.2Hz, 2H, NCH2), 2.11 (quint, J = 7.2Hz, 2H, CH2); 13C NMR (100 MHz, D2O) δ: 131.0, 130.2, 129.4, 128.9, 57.1, 51.1, 47.9, 19.2; IR n (cm-1): 3424 (br, s, OH), 1215 (SO), 1151 (SO); HRMS (ESI, m/z) calcd. for C17H21NO3S [M+H]+ m/z: 320.1315; found: 320.1313.
Claims (8)
1.一种取代高牛磺酸的制备方法,将硫代乙酸与式[1]所示的α,β-不饱和酰胺进行加成得到相应的式[2]所示的3-乙酰硫基酰胺,再经过还原和氧化得到式[4]所示的取代高牛磺酸;
其中:R1、R2、R3和R4表示氢、具有1~15个碳原子的烷基、具有3~15个碳原子的环烷基、具有4~15个碳原子的环烷基烷基、具有6~15个碳原子的芳基、具有7~15个碳原子的芳烷基,但R1、R2、R3和R4不同时为氢。
2.如权利要求1所述的取代高牛磺酸的制备方法,其特征在于所述加成反应的催化剂为三甲胺、三乙胺、三丙胺、三丁胺、三戊胺、乙基二异丙基胺、N,N-二甲基苯胺、N,N-二乙基苯胺、吡啶,二甲基吡啶,三甲基吡啶。
3.如权利要求1所述的取代高牛磺酸的制备方法,其特征在于所述的还原方法是氢化锂铝还原、硼烷还原、硼氢化钠和三氟化硼的混和物还原。
4.如权利要求1所述的取代高牛磺酸的制备方法,其特征在于氧化反应所用的催化剂为过氧甲酸、过氧乙酸、N-甲基吗啉N-氧化物。
5.如权利要求1所述的取代高牛磺酸的制备方法,其特征在于加成反应所用溶剂选自:二氯甲烷、氯仿、四氯化碳、二氯乙烷、三氯乙烷、四氯乙烷、四氯乙烯或它们的混和物。
6.如权利要求1所述的取代高牛磺酸的制备方法,其特征在于还原反应所用溶剂选自:乙醚、丙醚、四氢呋喃、二氧六环、乙二醇二甲醚或它们的混和物。
7.如权利要求1所述的取代高牛磺酸的制备方法,其特征在于氧化反应所用溶剂选自:甲酸、乙酸、丙酸、丁酸、戊酸、己酸、庚酸、辛酸、壬酸、癸酸、水或它们的混和物。
8.如权利要求1所述的取代高牛磺酸的制备方法,其特征在于所述反应在0oC~110oC的温度下搅拌反应。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210113527.6A CN102659643B (zh) | 2012-04-18 | 2012-04-18 | 一种由α,β-不饱和酰胺制备取代高牛磺酸的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210113527.6A CN102659643B (zh) | 2012-04-18 | 2012-04-18 | 一种由α,β-不饱和酰胺制备取代高牛磺酸的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102659643A CN102659643A (zh) | 2012-09-12 |
CN102659643B true CN102659643B (zh) | 2015-10-14 |
Family
ID=46769256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210113527.6A Expired - Fee Related CN102659643B (zh) | 2012-04-18 | 2012-04-18 | 一种由α,β-不饱和酰胺制备取代高牛磺酸的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102659643B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105152986B (zh) * | 2015-09-09 | 2017-08-25 | 武汉华纳联合药业有限公司 | 半胱氨酸‑高牛磺酸二肽及其衍生物及其医药用途 |
CN110668980A (zh) * | 2018-07-03 | 2020-01-10 | 浙江京新药业股份有限公司 | 一种2-取代的高牛磺酸衍生物 |
CN115160097B (zh) * | 2022-07-22 | 2024-05-28 | 温州大学 | 一种硫代乙酸还原n-o键合成酰胺的方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101255126A (zh) * | 2007-03-02 | 2008-09-03 | 北京大学 | 牛磺酸及其衍生物的制备 |
CN101337914A (zh) * | 2008-08-14 | 2009-01-07 | 北京化工大学 | 一种牛磺酸和取代牛磺酸的制备方法 |
CN101851182A (zh) * | 2010-06-03 | 2010-10-06 | 北京化工大学 | 一种取代牛磺酸的无盐制备方法 |
CN101851181A (zh) * | 2010-06-03 | 2010-10-06 | 北京化工大学 | 一种1-位取代牛磺酸的制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200843787A (en) * | 2006-12-29 | 2008-11-16 | Novabay Pharmaceuticals Inc | N-halogenated amino compounds and derivatives; compositions and methods of using them |
-
2012
- 2012-04-18 CN CN201210113527.6A patent/CN102659643B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101255126A (zh) * | 2007-03-02 | 2008-09-03 | 北京大学 | 牛磺酸及其衍生物的制备 |
CN101337914A (zh) * | 2008-08-14 | 2009-01-07 | 北京化工大学 | 一种牛磺酸和取代牛磺酸的制备方法 |
CN101851182A (zh) * | 2010-06-03 | 2010-10-06 | 北京化工大学 | 一种取代牛磺酸的无盐制备方法 |
CN101851181A (zh) * | 2010-06-03 | 2010-10-06 | 北京化工大学 | 一种1-位取代牛磺酸的制备方法 |
Non-Patent Citations (3)
Title |
---|
An Efficient Synthesis of N-Protected b-Aminoethanesulfonyl Chlorides:Versatile Building Blocks for the Synthesis of Oligopeptidosulfonamides;Arwin J. Brouwer等;《Synthesis》;20001231;第11卷;第1579–1584页 * |
New Coupling Reagents for the Preparation of Disulfide Cross-Linked Conjugates with Increased Stability;Silvia Arpicco等;《Bioconjugate Chem.》;19970528;第8卷;第327-337页 * |
孙昌俊 等.醛、酮的胺化还原及腈、肟、酰胺的还原.《有机化合物合成手册》.北京:化学工业出版社,2011,第670-685页. * |
Also Published As
Publication number | Publication date |
---|---|
CN102659643A (zh) | 2012-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Saibabu Kotti et al. | Vicinal diamino functionalities as privileged structural elements in biologically active compounds and exploitation of their synthetic chemistry | |
Qin et al. | Photoredox-catalyzed diamidation and oxidative amidation of alkenes: Solvent-enabled synthesis of 1, 2-diamides and α-amino ketones | |
Paz et al. | Carbon dioxide as a carbonylating agent in the synthesis of 2-oxazolidinones, 2-oxazinones, and cyclic ureas: Scope and limitations | |
Li et al. | Photomediated reductive coupling of nitroarenes with aldehydes for amide synthesis | |
CN102659643B (zh) | 一种由α,β-不饱和酰胺制备取代高牛磺酸的方法 | |
Cho et al. | Regiospecific rearrangement of hydroxylamines to secondary amines using diisobutylaluminum hydride | |
CN101735140A (zh) | 手性胺基化合物、合成方法及其抗流感药物达菲中间体的用途 | |
CN114599650A (zh) | DCN1/2介导的cullin类泛素化修饰的药学活性吡唑并-吡啶酮调节剂 | |
ES2494865T3 (es) | Método para producir alfa-aminoácido que contiene fósforo e intermedio de producción del mismo | |
MX2024014835A (es) | Metodo para sintetizar el compuesto de furoimidazopiridina, sustancia polimorfica y sustancia polimorfica de sal | |
Pindi et al. | N‐Phosphinyl Imine Chemistry (I): Design and Synthesis of Novel N‐Phosphinyl Imines and their Application to Asymmetric aza‐Henry Reaction | |
Palamini et al. | Iron-Catalyzed Synthesis of α-Azido α-Amino Esters via the Alkylazidation of Alkenes | |
CN110028422A (zh) | 一种咪唑盐酸盐催化氨基保护的方法 | |
Suman et al. | Metal-free synthesis of carbamoylated dihydroquinolinones via cascade radical annulation of cinnamamides with oxamic acids | |
CN101851181B (zh) | 一种1-位取代牛磺酸的制备方法 | |
Tikhonova et al. | Sulfur-mediated synthesis of unsymmetrically substituted N-aryl oxalamides by the cascade thioamidation/cyclocondensation and hydrolysis reaction | |
Henkes et al. | Synthesis and biochemical analysis of 2, 2, 3, 3, 4, 4, 5, 5, 6, 6, 7, 7-dodecafluoro-N-hydroxy-octanediamides as inhibitors of human histone deacetylases | |
CN102627587B (zh) | 一种由α,β-不饱和腈制备1-取代高牛磺酸的方法 | |
AU2013301410A1 (en) | Process for the preparation of sitagliptin and intermediate compounds | |
Kavitha et al. | Simple and an efficient method for the synthesis of 1-[2-dimethylamino-1-(4-methoxy-phenyl)-ethyl]-cyclohexanol hydrochloride:(±) venlafaxine racemic mixtures | |
KR100714197B1 (ko) | 보글리보스의 제조방법 | |
Linders et al. | Synthesis and binding properties of MK-801 isothiocyanates;(+)-3-isothiocyanato-5-methyl-10, 11-dihydro-5H-dibenzo [a, d] cyclohepten-5, 10-imine hydrochloride: a new, potent and selective electrophilic affinity ligand for the NMDA receptor-coupled phencyclidine binding site | |
BR102012028614A2 (pt) | Processo para a síntese de ivabradina e os sais de adição do mesmo com um ácido farmaceuticamente aceitável | |
CN102424665A (zh) | 一种1-取代高牛磺酸的制备方法 | |
Mohammed Khan et al. | Ultrasound-Assisted, Convenient and Widely Applicable 1, 1'-Carbonyl-diimidazole-Mediated |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151014 |